Myriam Almeida‐Jones1,2, Nai Yu Tang1,2, Aneela Reddy3, Evan Zahn1,2
Congenital Heart Disease, Vol.14, No.1, pp. 60-64, 2019, DOI:10.1111/chd.12712
Abstract Clinically significant patent ductus arteriosus (PDA) has been associated with signifi‐
cant morbidity in extremely low birth weight (ELBW) infants. Current management of
ELBW infants with hemodynamically significant PDA includes supportive treatment,
pharmacological therapy, and surgical ligation. All of these therapeutic options have
their advantages and limitations. More recently, transcatheter PDA closure has been
described as a viable option in this population. In this paper, we provide a compre‐
hensive review of this emerging procedure. More >
Login
Register
